Yuhui Yao

Dr. Yuhui Yao

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2023 in SSM - Population Health
Verified
Journal Article
Open access
QHQinglin Hu
Qinglin Hu
YYYuhui Yao
Yuhui Yao
JHJing Han
Jing Han
XYXin (Thomas) Yang
Xin (Thomas) Yang
JPJason Parton
Jason Parton
Little is known about the extent of geographic variation in online health record usage and related demographic characteristics in the United States. In order to examine geographical variation in the usage of online e-health records (EHR) patient portals in the US, and the sociodemographic factors effects on the access and use of the EHR patient's portal. This study using data from the 2019 and 2020 Health Information National Trends Survey. Specifically, predictors associated with accessing patients' EHR portal were examined. Furthermore, geographic variation of EHR portal’ availability and usage gap were examined and mapped. Respondents had significantly higher likelihood to access EHR portals when they are higher educated, willing to seek health information online, insured and had regular providers (adjusted OR = 2.01, 95% CI: 1.44 – 2.80; adjusted OR = 3.51, 95% CI: 2.49 – 4.94; adjusted OR = 2.38, 95% CI: 1.05 – 5.43; adjusted OR = 2.1, 95% CI: 1.51 – 2.92, respectively). Individuals living in Central-West, South regions or other non-urban areas as well as deprived urban areas are less likely to access their EHR portals (adjusted OR = 0.6, 95% CI: 0.41 – 0.89). Furthermore, we found that people living in the Midwest, Southern regions, and Mountain rural areas are more likely to have greater difficulties to access EHR than other regions. Therefore, populations residing in these underserved (deprived urban, rural or remote) areas tend to face more considerable obstacles to e-healthcare. Improve the disparities, accessibility, and educational initiatives on the usage of eHealth resources and encouragement from both healthcare providers and policymakers should be implemented with a particular focus on targeting non-urban areas and underserved population.

MSMichael Stellefson
Michael Stellefson
MWMin-Qi Wang
Min-Qi Wang
YYYuhui Yao
Yuhui Yao
OCOlivia Kathryn Campbell
Olivia Kathryn Campbell
RSRakshan Sivalingam
Rakshan Sivalingam
Despite growing recognition of the role that social determinants of health (SDOHs) and health-related social needs (HRSNs) play in chronic disease, limited research has examined their associations with Chronic Obstructive Pulmonary Disease (COPD) in population-based studies. This cross-sectional study analyzed 2022 Behavioral Risk Factor Surveillance System (BRFSS) data from 37 U.S. states and territories to determine how financial hardship, food insecurity, employment loss, healthcare access barriers, and psychosocial stressors influence the prevalence of COPD. Weighted logistic regression models were used to assess the associations between COPD and specific SDOHs and HRSNs. Several individual SDOH and HRSN factors were significantly associated with COPD prevalence, with financial strain emerging as a particularly strong predictor. In models examining specific SDOH factors, economic hardships like inability to afford medical care were strongly linked to higher COPD odds. Psychosocial HRSN risks, such as experiencing mental stress, also showed moderate associations with increased COPD prevalence. These findings suggest that addressing both structural and individual-level social risks may be critical for reducing the prevalence of COPD in populations experiencing financial challenges.

5 May 2026 in Journal of Quality Technology
Verified
Journal Article
Closed access
YYYuhui Yao
Yuhui Yao
CHChase Holcombe
Chase Holcombe
TTTyler Thomas
Tyler Thomas
SCSubhabrata Chakraborti
Subhabrata Chakraborti
JPJason M. Parton
Jason M. Parton
1. SPM (or SPC) consists of a collection of statistical techniques and methods used to monitor a process for maintaining and improving the quality of its products. SPC methods are widely used in ma...

1 November 2026 in JCO Precision Oncology
Verified
Journal Article
Open access
JHJeanne P. Homer
Jeanne P. Homer
MDMichael J. Demeure
Michael J. Demeure
YYYuhui Yao
Yuhui Yao
KHKristen Hanson
Kristen Hanson
BRBrenda Ramczyk
Brenda Ramczyk
CRCharité N. Ricker
Charité N. Ricker
Purpose: To estimate the relative and absolute risks (ARs) for ovarian, prostate, male and female breast, pancreatic, biliary tract, and colorectal cancers associated with germline BARD1 pathogenic and likely pathogenic variants (PVs/LPVs) because these risks have not previously been reported from a genotype-first perspective. Methods: We performed a secondary retrospective analysis of multicenter data comprising 445 three-generation pedigrees with confirmed BARD1 PVs/LPVs from 25 institutions nationwide. Data were aggregated at the family-relatedness level. The risks were estimated using a Bayesian survival model that incorporated information from the Surveillance, Epidemiology, and End Results (SEER) Program. Results: We confirmed the previously established increased risk for female breast cancer (relative risk [RR] = 3.53; 95% CI, 1.95 to 5.81; posterior probability [PP] = 0.0040) and found positive associations with female pancreatic cancer (RR = 3.76 [95% CI, 2.16-7.25]; PP < .0001), male pancreatic cancer (RR = 2.89 [95% CI, 1.66 to 5.61]; PP < .0001), and prostate cancer (RR = 3.02 [95% CI, 1.95 to 4.71]; PP < .0001). The predictive ARs to age 85 were 41.84% (95% CI, 23.09 to 68.91) for female breast cancer, 4.80% (95% CI, 2.76 to 9.25) for female pancreatic cancer, 3.98% (95% CI, 2.29 to 7.73) for male pancreatic cancer, and 36.11% (95% CI, 23.29 to 56.29) for prostate cancer. Risk estimates suggest an association for male breast, ovarian, and female colorectal cancers; however, the clinical significance is unclear, and these findings warrant cautious interpretation. In contrast, we found no evidence of association for biliary tract cancer or male colorectal cancer. Conclusion: These results support BARD1 's association with female breast cancer and suggest associations with pancreatic and prostate cancers. These findings have potential implications for genetic counseling and personalized risk management for male and female BARD1 PV/LPV heterozygotes.